iSpecimen Inc. (ISPC) Reports Q2 Loss of $0.87/sh

iSpecimen Inc. (NASDAQ: ISPC) reported Q2 EPS of ($0.87), versus ($0.19) reported last year. Revenue for the quarter came in at $2.9 million, versus $1.5 thousand reported last year.

For earnings history and earnings-related data on iSpecimen Inc. (ISPC) click here.

You May Also Be Interested In

• Four key things investors will watch in Nvidia's earnings next week
• Arbutus Biopharma (ABUS) Reports In-Line Q2 EPS
• BrainsWay Ltd. (BWAY) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Revenue Guidance